Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.33
+0.07 (1.33%)
Dec 5, 2025, 4:00 PM EST - Market closed
Candel Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Revenue | - | - | - | 0.13 | 0.13 | 0.13 | Upgrade
|
| Cost of Revenue | 23.07 | 18.23 | 23.59 | 20.35 | 14.59 | - | Upgrade
|
| Gross Profit | -23.07 | -18.23 | -23.59 | -20.22 | -14.47 | 0.13 | Upgrade
|
| Selling, General & Admin | 16.76 | 14.4 | 14.41 | 14.5 | 11.26 | 5.99 | Upgrade
|
| Research & Development | - | - | - | - | - | 7.94 | Upgrade
|
| Operating Expenses | 16.76 | 14.4 | 14.41 | 14.5 | 11.26 | 13.94 | Upgrade
|
| Operating Income | -39.83 | -32.63 | -38 | -34.72 | -25.73 | -13.81 | Upgrade
|
| Interest Expense | -1.09 | -2.09 | -2.6 | -1.71 | -0.05 | - | Upgrade
|
| Interest & Investment Income | 3.1 | 1.09 | 2.08 | 1.22 | - | 0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | 15.89 | -20.8 | 0.97 | 16.42 | -10.81 | -3.98 | Upgrade
|
| EBT Excluding Unusual Items | -21.94 | -54.44 | -37.55 | -18.79 | -36.59 | -17.68 | Upgrade
|
| Merger & Restructuring Charges | -0.7 | -0.7 | - | - | - | - | Upgrade
|
| Asset Writedown | -0.12 | -0.04 | -0.39 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.46 | - | Upgrade
|
| Pretax Income | -22.76 | -55.18 | -37.94 | -18.79 | -36.12 | -17.68 | Upgrade
|
| Net Income | -22.76 | -55.18 | -37.94 | -18.79 | -36.12 | -17.68 | Upgrade
|
| Net Income to Common | -22.76 | -55.18 | -37.94 | -18.79 | -36.12 | -17.68 | Upgrade
|
| Shares Outstanding (Basic) | 48 | 32 | 29 | 29 | 19 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 48 | 32 | 29 | 29 | 19 | 12 | Upgrade
|
| Shares Change (YoY) | 60.30% | 9.47% | 0.39% | 52.72% | 62.49% | 0.70% | Upgrade
|
| EPS (Basic) | -0.47 | -1.74 | -1.31 | -0.65 | -1.91 | -1.52 | Upgrade
|
| EPS (Diluted) | -0.47 | -1.74 | -1.31 | -0.65 | -1.91 | -1.52 | Upgrade
|
| Free Cash Flow | -33.74 | -27.04 | -34.7 | -32.72 | -24.05 | -10.55 | Upgrade
|
| Free Cash Flow Per Share | -0.70 | -0.85 | -1.20 | -1.14 | -1.27 | -0.91 | Upgrade
|
| Gross Margin | - | - | - | - | - | 100.00% | Upgrade
|
| Operating Margin | - | - | - | -27777.60% | -20580.80% | -11048.00% | Upgrade
|
| Profit Margin | - | - | - | -15035.20% | -28899.20% | -14144.00% | Upgrade
|
| Free Cash Flow Margin | - | - | - | -26172.80% | -19242.40% | -8437.60% | Upgrade
|
| EBITDA | -38.9 | -31.64 | -37.04 | -33.94 | -25.49 | -13.72 | Upgrade
|
| D&A For EBITDA | 0.93 | 0.99 | 0.96 | 0.78 | 0.23 | 0.09 | Upgrade
|
| EBIT | -39.83 | -32.63 | -38 | -34.72 | -25.73 | -13.81 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.